HAVRIX - 58160-826-34 - (Hepatitis A Vaccine)

Alphabetical Index


Drug Information of HAVRIX

Product NDC: 58160-826
Proprietary Name: HAVRIX
Non Proprietary Name: Hepatitis A Vaccine
Active Ingredient(s): 1440    [iU]/mL & nbsp;   Hepatitis A Vaccine
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of HAVRIX

Product NDC: 58160-826
Labeler Name: GlaxoSmithKline Biologicals SA
Product Type: VACCINE
FDA Application Number: BLA103475
Marketing Category: BLA
Start Marketing Date: 20070413

Package Information of HAVRIX

Package NDC: 58160-826-34
Package Description: 1 SYRINGE in 1 CARTON (58160-826-34) > 1 mL in 1 SYRINGE (58160-826-05)

NDC Information of HAVRIX

NDC Code 58160-826-34
Proprietary Name HAVRIX
Package Description 1 SYRINGE in 1 CARTON (58160-826-34) > 1 mL in 1 SYRINGE (58160-826-05)
Product NDC 58160-826
Product Type Name VACCINE
Non Proprietary Name Hepatitis A Vaccine
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRAMUSCULAR
Start Marketing Date 20070413
Marketing Category Name BLA
Labeler Name GlaxoSmithKline Biologicals SA
Substance Name HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)
Strength Number 1440
Strength Unit [iU]/mL
Pharmaceutical Classes Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Complete Information of HAVRIX


General Information